Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer

BACKGROUND: Prostate cancer growth is primarily driven by testosterone and 5α-dihydrotestosterone. Abiraterone is an irreversible inhibitor of CYP17, and CYP17 inhibition is a required step in testosterone biosynthesis. Previous studies have shown that abiraterone trough levels are predictive of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Myint, Zin W., Kolesar, Jill M., McCorkle, Joseph Robert, Wu, Jianrong, Ellis, Carleton S., Otto, Danielle E., Wang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578325/
https://www.ncbi.nlm.nih.gov/pubmed/36229939
http://dx.doi.org/10.12659/MSM.938091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578325/
https://www.ncbi.nlm.nih.gov/pubmed/36229939
http://dx.doi.org/10.12659/MSM.938091

Ejemplares similares